CMPX Compass Therapeutics0.92+0.02 (+2.1%)
CMPX Compass Therapeutics1.04-0.06 (-5.5%)
CMPX Compass Therapeutics1.37-0.45 (-24.7%)
Premarket Decliner
CMPX Compass Therapeutics1.82-0.08-4.2%
Premarket:1.08-0.74 (-40.7%)
Compass Therapeutics Provides Regulatory Update on Tovecimig in Biliary Tract Cancer Following FDA Feedback
Globe NewswireTue, 22-Sep 8:30 AM
CMPX Compass Therapeutics2.39+0.02 (+0.8%)
CMPX Compass Therapeutics2.41+0.10 (+4.3%)